Boston Scientific Corporation shares owned by ClearBridge Advisors
Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by ClearBridge Advisors
from 13F filings
Historical chart of ClearBridge Advisors investment in Boston Scientific Corporation
Tip: Access up to 7 years of quarterly data
All positions including Boston Scientific Corporation held by ClearBridge Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Boston Scientific Corporation by ClearBridge Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $143M | 2.3M | 62.75 |
| 2025-12-31 | $70M | 733k | 95.35 |
| 2025-09-30 | $279k | 2.9k | 97.63 |
| 2025-06-30 | $316k | 2.9k | 107.41 |
| 2025-03-31 | $305k | 3.0k | 100.88 |
| 2024-12-31 | $295k | 3.3k | 89.32 |
| 2024-09-30 | $352k | 4.2k | 83.80 |
| 2024-06-30 | $441k | 5.7k | 77.01 |
| 2024-03-31 | $423k | 6.2k | 68.49 |
| 2023-12-31 | $361k | 6.2k | 57.81 |
| 2023-09-30 | $289k | 5.5k | 52.80 |
| 2023-06-30 | $352k | 6.5k | 54.09 |
| 2023-03-31 | $326k | 6.5k | 50.03 |
| 2022-12-31 | $304k | 6.6k | 46.27 |
| 2022-03-31 | $210k | 4.7k | 44.26 |
| 2021-12-31 | $226k | 5.3k | 42.46 |
| 2021-09-30 | $231k | 5.3k | 43.40 |
| 2020-09-30 | $283k | 7.4k | 38.17 |
| 2020-06-30 | $308k | 8.8k | 35.12 |
| 2020-03-31 | $279k | 8.5k | 32.69 |
| 2019-12-31 | $387k | 8.5k | 45.32 |
| 2019-09-30 | $345k | 8.5k | 40.73 |
| 2019-06-30 | $377k | 8.8k | 43.02 |
| 2019-03-31 | $255k | 6.7k | 38.33 |
| 2018-12-31 | $235k | 6.7k | 35.31 |
| 2018-09-30 | $240k | 6.2k | 38.47 |
| 2018-06-30 | $106k | 3.2k | 32.84 |
| 2015-12-31 | $4.0k | 236 | 16.95 |
| 2013-12-31 | $3.0k | 215 | 13.95 |
| 2013-09-30 | $3.0k | 215 | 13.95 |
| 2013-06-30 | $2.0k | 215 | 9.30 |
| 2013-03-31 | $2.0k | 215 | 9.30 |
| 2012-12-31 | $999 | 215 | 4.65 |
| 2012-06-30 | $999 | 215 | 4.65 |
| 2012-03-31 | $2.0k | 215 | 9.30 |
Top funds holding Boston Scientific Corporation
View all funds holding Boston Scientific Corporation